In recent years, different urinary markers such as the Bladder Epicheck® have been developed in an attempt to reduce the number of cystoscopies in the follow-up of non-muscle invasive bladder cancer (NMIBC).
To provide a systematic review of Bladder Epicheck® and its current clinical utility in the follow-up and detection of recurrence of NMIBC.
Systematic review based on a literature search of PubMed, Web of Science and Scopus databases until October 2023, according to PRISMA and Quadas-2 criteria. Sensitivity (Se), specificity (Sp), positive predictive value (PPV) and negative predictive value (NPV) of the marker were calculated. Diagnostic performance was evaluated by the area under the curve (AUC).
Fifteen studies were analyzed (n = 3761) including 86.7% prospective studies. Of the patient series, 53.2% had received previous intravesical instillations. The mean Se of the biomarker in the detection of recurrence varied according to tumor grade (87.9%-high grade/HG vs. 44.9%-low grade/LG, respectively). Their weighted mean Se and Sp were 71.6% and 84.5%, respectively. The mean recurrence rate was 29.1%. The weighted mean PPV and NPV were 56.4% and 92.8% (97.7% non-LG),respectively. The mean AUC was 85.63%.
Bladder Epicheck® is a useful urinary marker in the follow-up of NMIBC, with significantly high Se and NPV in the detection of recurrences, especially in cases of HG disease. Its use can reduce the number of cystoscopies required in the follow-up of NMIBC, improving the quality of life of patients and potentially increasing health economic savings.
Actas urologicas espanolas. 2024 May 10 [Epub ahead of print]
J Caño Velasco, S Artero Fullana, L Polanco Pujol, A Lafuente Puentedura, J D Subiela, J Aragón Chamizo, M Moralejo Gárate, C Hernández Fernández
Servicio de Urología, Hospital General Universitario Gregorio Marañón, Madrid, Spain. Electronic address: ., Servicio de Urología, Hospital General Universitario Gregorio Marañón, Madrid, Spain., Servicio de Urología, Hospital Universitario Ramón y Cajal, Madrid, Spain.
PubMed http://www.ncbi.nlm.nih.gov/pubmed/38735433